BCR-ABL1 kinase domain mutation screening using next generation sequencing in CML and Ph plus ALL patients

Eitemau Tebyg

• Consensus on BCR-ABL1 reporting in chronic myeloid leukaemia in the UK
  gan: Cross, N, et al.
  Cyhoeddwyd: (2018)
• Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules.
  gan: Berke, Z, et al.
  Cyhoeddwyd: (2000)
• Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia.
  gan: Foroni, L, et al.
  Cyhoeddwyd: (2011)
• Simvastatin enhances the efficacy of Bcr-Abl tyrosine kinase inhibitor nilotinib in chronic myeloid leukemia.
  gan: Koh, Yanqing.
  Cyhoeddwyd: (2011)
• Detection of bcr-abl Fusion Gene Expression in Chronic Myelogenous
  gan: Perpustakaan UGM, i-lib
  Cyhoeddwyd: (2004)